tradingkey.logo

AxoGen Inc

AXGN

12.550USD

-0.120-0.95%
Fechamento 08/04, 16:00ETCotações atrasadas em 15 min
571.18MValor de mercado
PerdaP/L TTM

AxoGen Inc

12.550

-0.120-0.95%
Mais detalhes de AxoGen Inc Empresa
Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its products include Avance nerve graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, Axotouch Two-Point Discriminator and Axoguard HA+ Nerve Protector. Avance nerve graft is a biologically active processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site. Axoguard Nerve Connector is a porcine submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce nerve reconstruction while preventing soft tissue attachment. Axotouch Two-Point Discriminator is used to measure the innervation density of any surface area of the skin.
Informações da empresa
Código da empresaAXGN
Nome da EmpresaAxoGen Inc
Data de listagemDec 17, 1986
CEOMr. Michael Donald (Mike) Dale
Número de funcionários451
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 17
Endereço13631 Progress Blvd.
CidadeALACHUA
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal32615
Telefone13864626817
Sitehttps://www.axogeninc.com/
Código da empresaAXGN
Data de listagemDec 17, 1986
CEOMr. Michael Donald (Mike) Dale
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Erick Wayne Devinney
Mr. Erick Wayne Devinney
Chief Innovation Officer
Chief Innovation Officer
150.41K
-30.16%
Mr. Paul G. Thomas
Mr. Paul G. Thomas
Independent Chairman of the Board
Independent Chairman of the Board
21.40K
-38.73%
Ms. Lindsey Hartley
Ms. Lindsey Hartley
Chief Financial Officer
Chief Financial Officer
20.76K
--
Mr. Jens Schroeder Kemp
Mr. Jens Schroeder Kemp
Chief Marketing Officer
Chief Marketing Officer
12.68K
-54.18%
Mr. Rick Ditto
Mr. Rick Ditto
Vice President - Global Health Economics, Reimbursement & Policy
Vice President - Global Health Economics, Reimbursement & Policy
--
--
Mr. John H. Johnson
Mr. John H. Johnson
Independent Director
Independent Director
--
--
Ms. Kathy Weiler
Ms. Kathy Weiler
Independent Director
Independent Director
--
--
Mr. Marc A. Began
Mr. Marc A. Began
Executive Vice President, Chief Compliance Officer, General Counsel
Executive Vice President, Chief Compliance Officer, General Counsel
--
--
Mr. William P. (Bill) Burke
Mr. William P. (Bill) Burke
Independent Director
Independent Director
--
--
Mr. Alan M. Levine
Mr. Alan M. Levine
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Erick Wayne Devinney
Mr. Erick Wayne Devinney
Chief Innovation Officer
Chief Innovation Officer
150.41K
-30.16%
Mr. Paul G. Thomas
Mr. Paul G. Thomas
Independent Chairman of the Board
Independent Chairman of the Board
21.40K
-38.73%
Ms. Lindsey Hartley
Ms. Lindsey Hartley
Chief Financial Officer
Chief Financial Officer
20.76K
--
Mr. Jens Schroeder Kemp
Mr. Jens Schroeder Kemp
Chief Marketing Officer
Chief Marketing Officer
12.68K
-54.18%
Mr. Rick Ditto
Mr. Rick Ditto
Vice President - Global Health Economics, Reimbursement & Policy
Vice President - Global Health Economics, Reimbursement & Policy
--
--
Mr. John H. Johnson
Mr. John H. Johnson
Independent Director
Independent Director
--
--
Detalhamento da receita
FY2023
FY2022
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
United States
159.01M
0.00%
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: sáb, 17 de mai
Atualizado em: sáb, 17 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
First Light Asset Management, LLC
9.82%
BlackRock Institutional Trust Company, N.A.
6.87%
The Vanguard Group, Inc.
5.55%
ArrowMark Colorado Holdings, LLC
3.49%
Morgan Stanley & Co. LLC
3.48%
Other
70.78%
Investidores
Investidores
Proporção
First Light Asset Management, LLC
9.82%
BlackRock Institutional Trust Company, N.A.
6.87%
The Vanguard Group, Inc.
5.55%
ArrowMark Colorado Holdings, LLC
3.49%
Morgan Stanley & Co. LLC
3.48%
Other
70.78%
Tipos de investidores
Investidores
Proporção
Investment Advisor/Hedge Fund
38.46%
Investment Advisor
27.64%
Hedge Fund
14.22%
Research Firm
5.24%
Individual Investor
4.80%
Pension Fund
0.48%
Bank and Trust
0.32%
Sovereign Wealth Fund
0.17%
Venture Capital
0.05%
Other
8.62%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
352
41.63M
91.41%
-2.42M
2025Q1
357
42.08M
92.45%
-1.70M
2024Q4
343
39.00M
87.97%
-5.62M
2024Q3
323
39.49M
90.05%
-1.54M
2024Q2
302
38.53M
87.94%
-4.16M
2024Q1
307
37.61M
87.02%
-4.05M
2023Q4
318
35.68M
82.81%
-5.15M
2023Q3
322
35.50M
82.64%
-5.39M
2023Q2
319
36.28M
84.47%
-3.01M
2023Q1
324
35.99M
84.11%
-3.05M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
First Light Asset Management, LLC
4.47M
9.82%
-32.58K
-0.72%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.13M
6.87%
+93.19K
+3.07%
Mar 31, 2025
The Vanguard Group, Inc.
2.53M
5.55%
+103.94K
+4.28%
Mar 31, 2025
ArrowMark Colorado Holdings, LLC
1.59M
3.49%
-657.69K
-29.25%
Mar 31, 2025
Morgan Stanley & Co. LLC
1.59M
3.48%
-105.62K
-6.24%
Mar 31, 2025
Soleus Capital Management, L.P.
1.45M
3.18%
-1.51M
-51.08%
Mar 31, 2025
Driehaus Capital Management, LLC
1.17M
2.57%
+217.59K
+22.80%
Mar 31, 2025
Zaderej (Karen L)
1.14M
2.51%
+71.04K
+6.62%
Mar 21, 2024
Geode Capital Management, L.L.C.
1.03M
2.25%
+19.92K
+1.98%
Mar 31, 2025
Assenagon Asset Management S.A.
1.00M
2.2%
+174.68K
+21.13%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
ROBO Global Healthcare Technology & Innovation ETF
1.87%
SPDR S&P Health Care Equipment ETF
1.2%
iShares Neuroscience and Healthcare ETF
1.14%
Fidelity Digital Health ETF
0.89%
Invesco NASDAQ Future Gen 200 ETF
0.45%
AAM Sawgrass US Small Cap Quality Growth ETF
0.44%
Fidelity Enhanced Small Cap ETF
0.13%
Vanguard US Momentum Factor ETF
0.11%
iShares Micro-Cap ETF
0.11%
Franklin US Small Cap Multifactor Index ETF
0.07%
Ver Mais
ROBO Global Healthcare Technology & Innovation ETF
Proporção1.87%
SPDR S&P Health Care Equipment ETF
Proporção1.2%
iShares Neuroscience and Healthcare ETF
Proporção1.14%
Fidelity Digital Health ETF
Proporção0.89%
Invesco NASDAQ Future Gen 200 ETF
Proporção0.45%
AAM Sawgrass US Small Cap Quality Growth ETF
Proporção0.44%
Fidelity Enhanced Small Cap ETF
Proporção0.13%
Vanguard US Momentum Factor ETF
Proporção0.11%
iShares Micro-Cap ETF
Proporção0.11%
Franklin US Small Cap Multifactor Index ETF
Proporção0.07%
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI